SARS-CoV Spike antibody (AA 1124-1140)
Quick Overview for SARS-CoV Spike antibody (AA 1124-1140) (ABIN199984)
Target
See all SARS-CoV Spike (SARS-CoV S) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1124-1140
-
Specificity
- Full length Spike protein transfected into UM92 cells was used as a positive control and an approximate 139 kD band was observed.
-
Purification
- Protein G purified
-
Immunogen
-
Type of Immunogen: Native protein
-
-
-
-
Application Notes
- Approved: WB (5 μg/mL)
-
Comment
-
Target Species of Antibody: SARS Coronavirus
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, 0.2 % gelatin, 0.05 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
-
: "A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters. ..." in: Nature communications, Vol. 12, Issue 1, pp. 6277, (2021) (PubMed).
-
: "A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters. ..." in: Nature communications, Vol. 12, Issue 1, pp. 6277, (2021) (PubMed).
-
- SARS-CoV Spike (SARS-CoV S) (SARS-Coronavirus Spike Protein (SARS-CoV S))
-
Alternative Name
- SARS-CoV Spike
-
Target Type
- Viral Protein
-
Background
-
Name/Gene ID: S
Family: Virion Structure
Synonyms: S, E2, S E2 glycoprotein, E2 glycoprotein precursor -
Gene ID
- 1489668
Target
-